P. gingivalis lipopolysaccharide intensifies inflammation post-myocardial infarction through matrix metalloproteinase-9

Journal of Molecular and Cellular Cardiology

Volumn 76, Issue , 2014, Pages 218-226

  DeLeon Pennell, Kristine Y ^a   de Castro Brás, Lisandra E ^a   Iyer, Rugmani Padmanabhan ^a   Bratton, Dustin R ^a   Jin, Yu Fang ^a,b   Ripplinger, Crystal M ^c   Lindsey, Merry L ^a,d  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d G V SONNY MONTGOMERY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cardiac function; Matrix metalloproteinase 9; Myocardial infarction; Periodontal disease; Porphyromonas gingivalis; Proteomics

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GELATINASE B; AUTACOID; LIPOPOLYSACCHARIDE; MMP9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CHEMOTAXIS; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME BLOOD LEVEL; ENZYME MECHANISM; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE INFARCTION; HEART VENTRICLE HYPERTROPHY; LONG TERM EXPOSURE; M1 MACROPHAGE; MACROPHAGE; MALE; MOUSE; MYOCARDITIS; NONHUMAN; PORPHYROMONAS GINGIVALIS; PROTEIN EXPRESSION; WILD TYPE; ANIMAL; BACTEROIDACEAE INFECTION; BLOOD; C57BL MOUSE; CELL MOTION; COMPLICATION; ENZYMOLOGY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; PERIODONTAL DISEASE;

PORPHYROMONAS GINGIVALIS;

ANIMALS; BACTEROIDACEAE INFECTIONS; CELL MOVEMENT; FEMALE; GENE EXPRESSION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 9; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS;

EID: 84907773541     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.09.007     Document Type: Article

References (43)

1. Kaisare S., Rao J., Dubashi N. Periodontal disease as a risk factor for acute myocardial infarction. A case-control study in Goans highlighting a review of the literature. Br Dent J 2007, 203:E5. [discussion 144-5].
2. Tonetti M.S., D'Aiuto F., Nibali L., Donald A., Storry C., Parkar M., et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007, 356:911-920.
3. Holmlund A., Holm G., Lind L. Number of teeth as a predictor of cardiovascular mortality in a cohort of 7,674 subjects followed for 12years. J Periodontol 2010, 81:870-876.
4. Humphrey L.L., Fu R., Buckley D.I., Freeman M., Helfand M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med 2008, 23:2079-2086.
5. Papantonopoulos G., Takahashi K., Bountis T., Loos B.G. Artificial neural networks for the diagnosis of aggressive periodontitis trained by immunologic parameters. PLoS One 2014, 9:e89757.
6. Schenkein H.A., Loos B.G. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Periodontol 2013, 84:S51-S69.
7. Shaddox L.M., Wiedey J., Calderon N.L., Magnusson I., Bimstein E., Bidwell J.A., et al. Local inflammatory markers and systemic endotoxin in aggressive periodontitis. J Dent Res 2011, 90:1140-1144.
8. Oliveira F.J., Vieira R.W., Coelho O.R., Petrucci O., Oliveira P.P., Antunes N., et al. Systemic inflammation caused by chronic periodontite in patients victims of acute ischemic heart attack. Rev Bras Cir Cardiovasc 2010, 25:51-58.
9. Pussinen P.J., Vilkuna-Rautiainen T., Alfthan G., Palosuo T., Jauhiainen M., Sundvall J., et al. Severe periodontitis enhances macrophage activation via increased serum lipopolysaccharide. Arterioscler Thromb Vasc Biol 2004, 24:2174-2180.
10. Kojima T., Yasui S., Ishikawa I. Distribution of Porphyromonas gingivalis in adult periodontitis patients. J Periodontol 1993, 64:1231-1237.
11. Missailidis C.G., Umeda J.E., Ota-Tsuzuki C., Anzai D., Mayer M.P. Distribution of fimA genotypes of Porphyromonas gingivalis in subjects with various periodontal conditions. Oral Microbiol Immunol 2004, 19:224-229.
12. Deleon-Pennell K.Y., Bras L.E., Lindsey M.L. Circulating lipopolysaccharide resets cardiac homeostasis in mice through a matrix metalloproteinase-9 dependent mechanism. Physiol Rep 2013, 1:e00079.
13. Luttun A., Lutgens E., Manderveld A., Maris K., Collen D., Carmeliet P., et al. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation 2004, 109:1408-1414.
14. Bradley L.M., Douglass M.F., Chatterjee D., Akira S., Baaten B.J. Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling. PLoS Pathog 2012, 8:e1002641.
15. Ducharme A., Frantz S., Aikawa M., Rabkin E., Lindsey M., Rohde L.E., et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 2000, 106:55-62.
16. Lindsey M.L., Escobar G.P., Dobrucki L.W., Goshorn D.K., Bouges S., Mingoia J.T., et al. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. Am J Physiol Heart Circ Physiol 2006, 290:H232-H239.
17. Vu T.H., Shipley J.M., Bergers G., Berger J.E., Helms J.A., Hanahan D., et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998, 93:411-422.
18. Salto-Tellez M., Yung Lim S., El Oakley R.M., Tang T.P.L., Almsherqi Z.A.M., Lim S.-K. Myocardial infarction in the C57BL/6J mouse: a quantifiable and highly reproducible experimental model. Cardiovasc Pathol 2004, 13:91-97.
19. Zamilpa R., Kanakia R., Cigarroa Jt, Dai Q., Escobar G.P., Martinez H., et al. CC chemokine receptor 5 deletion impairs macrophage activation and induces adverse remodeling following myocardial infarction. Am J Physiol Heart Circ Physiol 2011, 300:H1418-H1426.
20. Chiao Y.A., Dai Q., Zhang J., Lin J., Lopez E.F., Ahuja S.S., et al. Multi-analyte profiling reveals matrix metalloproteinase-9 and monocyte chemotactic protein-1 as plasma biomarkers of cardiac aging. Circ Cardiovasc Genet 2011, 4:455-462.
21. Ma Y., Halade G.V., Zhang J., Ramirez T.A., Levin D., Voorhees A., et al. Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation. Circ Res 2013, 112:675-688.
22. Ramirez T.A., Iyer R.P., Ghasemi O., Lopez E.F., Levin D.B., Zhang J., et al. Aliskiren and valsartan mediate left ventricular remodeling post-myocardial infarction in mice through MMP-9 effects. J Mol Cell Cardiol 2014, 72:326-335.
23. Tao Z.Y., Cavasin M.A., Yang F., Liu Y.H., Yang X.P. Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice. Life Sci 2004, 74:1561-1572.
24. Duluc D., Delneste Y., Tan F., Moles M.P., Grimaud L., Lenoir J., et al. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 2007, 110:4319-4330.
25. Fairweather D., Cihakova D. Alternatively activated macrophages in infection and autoimmunity. J Autoimmun 2009, 33:222-230.
26. Roca H., Varsos Z.S., Sud S., Craig M.J., Ying C., Pienta K.J. CCL2 and interleukin-6 promote survival of human CD11b+peripheral blood mononuclear cells and induce M2-type macrophage polarization. J Biol Chem 2009, 284:34342-34354.
27. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012, 122:787-795.
28. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325:612-616.
29. Fujiu K., Wang J., Nagai R. Cardioprotective function of cardiac macrophages. Cardiovasc Res 2014, 102:232-239.
30. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140:871-882.
31. Bekes E.M., Schweighofer B., Kupriyanova T.A., Zajac E., Ardi V.C., Quigley J.P., et al. Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am J Pathol 2011, 179:1455-1470.
32. Puhakka M., Magga J., Hietakorpi S., Penttila I., Uusimaa P., Risteli J., et al. Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation. J Card Fail 2003, 9:325-332.
33. Lambert J.M., Lopez E.F., Lindsey M.L. Macrophage roles following myocardial infarction. Int J Cardiol 2008, 130:147-158.
34. Green C.E., Schaff U.Y., Sarantos M.R., Lum A.F., Staunton D.E., Simon S.I. Dynamic shifts in LFA-1 affinity regulate neutrophil rolling, arrest, and transmigration on inflamed endothelium. Blood 2006, 107:2101-2111.
35. Takada Y., Ye X., Simon S. The integrins. Genome Biol 2007, 8:215.
36. Ertl G., Frantz S. Healing after myocardial infarction. Cardiovasc Res 2005, 66:22-32.
37. Hollborn M., Stathopoulos C., Steffen A., Wiedemann P., Kohen L., Bringmann A. Positive feedback regulation between MMP-9 and VEGF in human RPE cells. Invest Ophthalmol Vis Sci 2007, 48:4360-4367.
38. Payne T.R., Oshima H., Okada M., Momoi N., Tobita K., Keller B.B., et al. A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol 2007, 50:1677-1684.
39. Mishra P.K., Pathi V., Murday A. Post myocardial infarction left ventricular free wall rupture. Interact Cardiovasc Thorac Surg 2007, 6:39-42.
40. Heymans S., Luttun A., Nuyens D., Theilmeier G., Creemers E., Moons L., et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999, 5:1135-1142.
41. Romanic A.M., Burns-Kurtis C.L., Gout B., Berrebi-Bertrand I., Ohlstein E.H. Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit. Life Sci 2001, 68:799-814.
42. Scannapieco F.A., Bush R.B., Paju S. Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease. A systematic review. Ann Periodontol 2003, 8:54-69.
43. Pussinen P.J., Tuomisto K., Jousilahti P., Havulinna A.S., Sundvall J., Salomaa V. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol 2007, 27:1433-1439.